Class IIITerminatedD-0801-2021
Drug recall · September 22, 2021
Glycopyrrolate Injection recall
Why: Failed Impurities/Degradation Specifications
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Glycopyrrolate Injection, USP 4mg per 20mL, 20 mL Multi-Dose Vials, Rx only, Mfd for Meitheal Pharmaceuticals, Chicago, IL 60631. NDC 71288-408-21
- Lots / codes
Lot #: G0010120, Exp. Date December 2021; G0080520, Exp. Date April 2022; G0090221, G0100221, Exp. Date January 2023
- Quantity
- 1,160 ten-pack cartons
- Company
- Meitheal Pharmaceuticals Inc, Chicago, IL
- Distribution
- Nationwide within the USA and India
- Initiated
- September 3, 2021 · Voluntary: Firm initiated
- Classified
- September 15, 2021
- Reported
- September 22, 2021
- Ended
- May 12, 2024
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.